Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Indivior Plc (INDV.LN)

Indivior Plc (INDV.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,003,753
  • Shares Outstanding, K 127,219
  • Annual Sales, $ 1,093 M
  • Annual Income, $ 2,000 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales 1.19
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings $0.03 on 10/24/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend 0.365 on 06/16/16
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
554.500 +42.38%
on 10/14/24
817.000 -3.37%
on 11/12/24
+203.090 (+34.63%)
since 10/11/24
3-Month
554.500 +42.38%
on 10/14/24
1,009.000 -21.75%
on 08/15/24
-178.000 (-18.40%)
since 08/12/24
52-Week
554.500 +42.38%
on 10/14/24
1,770.000 -55.40%
on 03/05/24
-503.500 (-38.94%)
since 11/10/23

Most Recent Stories

More News
Stocks Set to Open Lower as Investors Await Key U.S. Inflation Data and Big Tech Earnings

December S&P 500 futures (ESZ23) are down -0.76%, and December Nasdaq 100 E-Mini futures (NQZ23) are down -0.92% this morning as the benchmark U.S. 10-year yield hit 5% for the first time since 2007 while...

ESZ23 : 4,694.27s (-0.58%)
NQZ23 : 16,530.23s (-0.07%)
SEDG : 12.21 (-10.75%)
AXP : 289.70 (-1.12%)
RF : 26.25 (+0.19%)
KNX : 56.61 (-3.86%)
MSFT : 423.13 (+1.22%)
GOOGL : 181.85 (+0.83%)
V : 309.73 (-0.19%)
KO : 63.47 (+0.17%)
META : 586.90 (+0.64%)
BA : 146.12 (-1.91%)
Indivior to Commence Trading on Nasdaq

/PRNewswire/ -- Indivior PLC (LSE: INDV), a global pharmaceutical company working to help change patients' lives by developing medicines to treat substance use...

INDV.LN : 789.500 (-1.31%)
Indivior Reaches Agreement with States' Attorneys General and District of Columbia to Resolve Antitrust Multi-District Litigation Claims

/PRNewswire/ -- Indivior PLC (LSE: INDV), a leading addiction treatment company, announced that its subsidiary, Indivior Inc. (the "Company"), has reached an...

INDV.LN : 789.500 (-1.31%)
Indivior To Participate In Upcoming Investor Conferences

/PRNewswire/ -- Indivior PLC (LSE: INDV) today announced that it will participate in the following investor events: Jefferies Healthcare Conference – New York...

INDV.LN : 789.500 (-1.31%)
Indivior PLC Form 20-F Registration Statement for Additional US Listing Now Available; Trading on NASDAQ Expected to Commence on June 12th

/PRNewswire/ -- Indivior PLC (LSE: INDV) today announced that its registration statement on Form 20-F required for the additional U.S. listing of its ordinary...

INDV.LN : 789.500 (-1.31%)
Indivior Announces Q1 2023 Financial Results

/PRNewswire/ -- Indivior PLC (LSE: INDV) today announced its financial results for the period ending March 31, 2023. The earnings release, investor...

INDV.LN : 789.500 (-1.31%)
Indivior To Participate In Bank of America Global Healthcare Conference 2023

/PRNewswire/ -- Indivior PLC (LSE: INDV) today announced that it will participate in the following investor event: Bank of America Global Healthcare Conference...

INDV.LN : 789.500 (-1.31%)
Indivior Completes Acquisition of Opiant Pharmaceuticals, Inc.

/PRNewswire/ -- Indivior PLC (LSE: INDV) ("Indivior" or the "Company") today announced that it has completed the acquisition of Opiant Pharmaceuticals, Inc....

INDV.LN : 789.500 (-1.31%)
FY 2022 Financial Results Announced

/PRNewswire/ -- Indivior PLC (LSE: INDV) today announced 2022 Full Year Results. The earnings release, investor presentation, and webcast are available at...

INDV.LN : 789.500 (-1.31%)
Indivior Announces Q3 2022 Financial Results

/PRNewswire/ -- Indivior PLC (LON: INDV) today announced its financial results for the period ending September 30, 2022. The earnings release, investor...

INDV.LN : 789.500 (-1.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 831.500
2nd Resistance Point 817.000
1st Resistance Point 808.500
Last Price 789.500
1st Support Level 785.500
2nd Support Level 771.000
3rd Support Level 762.500

See More

52-Week High 1,770.000
Fibonacci 61.8% 1,305.679
Fibonacci 50% 1,162.250
Fibonacci 38.2% 1,018.821
Last Price 789.500
52-Week Low 554.500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar